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Introduction
• Post-operative nausea and vomiting (PONV) is any nausea or 
vomiting that follows immediately after and up to 48 hours 
after surgery (Pierre & Whelan, 2012)
• PONV is one of the biggest and most common complaints 
and one out of three surgical patients will experience it 
(Pierre & Whelan, 2012)
• It is debilitating and can cause serious consequences to the 
patient and to the hospital
• Risk factors for PONV: female gender, non-smoker, 
perioperative opioid use, history of PONV or motion 
sickness, and certain surgeries such as gynecological, 
laparoscopic, ophthalmological, ontological, and ear-nose-
throat (Pierre & Whelan, 2012)
• To decrease the incidence, a multimodal approach is used 
perioperatively
• Different anti-emetic medications are used in combination 
to work on the multiple receptors that affect the vomiting 
center
• Receptors that affect the vomiting center: serotonin (5-HT3), 
dopamine 2 (D2), neurokinin 1 (NK1), histamine 1 (H1), and 
muscarinic acetylcholine (mAch) (Pierre & Whelan, 2012)
• When using multiple medications and therapies to block 
receptors, 98% of patients did not develop PONV 
(Chatterjee, Rudra, & Sengupta, 2011)
Pathophysiology 
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Pathophysiological Significance
Signs and Symptoms
Conclusion
Implications for Nursing
• PONV is complex and not well understood 
• The vomiting center is stimulated by the glossopharyngeal, 
hypoglossal, and vagal nerves
• The chemoreceptor trigger zone (CRTZ) and the nucleus tractus
solitaries (NTS) are located in the brain stem and send signals to 
the vomiting center (Pierre et al., 2012)
• Vagal afferent nerves, vestibular system, and the limbic system 
can stimulate the vomiting center (Chatterjee et al., 2011)
• There are several receptors that will stimulate nausea and 
vomiting 
• mAch receptors signal the vomiting center to cause nausea and 
vomiting 
• Circulating substances in the blood, such as toxins, activates D1 
and 5HT3 in the CRTZ  which sends signals to the vomiting center 
(Hasudungan, 2013)
• Motion sickness activates the vestibulocochlear nerve, stimulating 
H1 and mAch receptors, which then stimulates the CRTZ, and then 
the vomiting center (Hasudungan, 2013). 
• The higher center of the brain is activated by painful stimuli, 
rancid smells, and corrupt scenes which activate the vomiting 
center (Hasudungan, 2013)
• Vagal sensory nerve fibers in the stomach are stimulated from 
certain foods or toxins that irritate the gastric lining which then 
stimulate the vomiting center (Hasudungan, 2013)
• The vomiting center can be triggered by opioids, volatile 
anesthetics, drug reactions, anticholinergics, nitrous oxide, 
dehydration, anxiety, pain, and motion
• Anesthesia providers need to be aware of the risk factors, 
pathophysiology, high risk medications, and preventative strategies 
for PONV 
• By knowing the pathophysiology of PONV and getting a detailed 
history from the patient, the anesthesia provider can determine the 
appropriate multimodal approach for each individual patient, and 
decrease the chance of the patient getting PONV
• PONV prevention is essential for safe patient care
• The CRNA should have a planned multimodal approach, 
specified for each patient
• One third of patients without prophylaxis will develop PONV 
(Chatterjee et al., 2011)
• Consequences of PONV include delayed discharge from PACU, 
unanticipated hospital stays, pulmonary aspiration, patient 
discomfort, and dehiscence of surgical incision (Chatterjee et 
al., 2011).
• Anesthesia provides can significantly improve the quality of 
patient care and satisfaction if they are able to identify high-risk 
patients and know the appropriate prophylactic treatment 
(Chatterjee et al., 2011)
• PONV will occur immediately after and up to 48 hours 
post-surgery
• Uneasiness of the stomach, gagging, reflux of gastric 
contents, involuntary and forceful contraction of the 
stomach resulting in expulsion of gastric contents
• Not able to hold food or fluids down without gagging or 
vomiting
• Fatigue, dehydration, headache, lightheadedness, 
dizziness, pain, and dehiscence of the surgical incision
• PONV is very serious because it can be debilitating for the patient 
and cause complications 
• Regional anesthesia and NSAIDs should be used to decrease the 
use of opioids (Chatterjee et al., 2011)
• N2O, inhalational agents, Etomidate, and Ketamine should be 
avoided because they are emetogenic agents 
• Anticholinesterases should be used correctly based on the need for 
neuromuscular blockade reversal due to their ability to cause 
PONV (Chatterjee et al., 2011)
• Total intravenous anesthesia (TIVA) is another strategy to prevent 
PONV 
• Use different anti-emetics that work on all five receptors: 5HT3, 
D2, H1, NK1, mAch
• The most common medications used are Zofran, Dexamethasone, 
Promethazine, Scopolamine, Metoclopramide, and Emend
• Consider using an anxiolytic and aggressive hydration at 25ml/kg 
(Chatterjee et al., 2011)
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